The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
How Much Growth In Market Value Is Expected For The Cardiovascular Calcification Market Between 2026 And 2030?
The cardiovascular calcification market has experienced significant expansion recently. It is projected to expand from $1.9 billion in 2025 to reach $2.05 billion by 2026, demonstrating a compound annual growth rate (CAGR) of 7.7%. Historically, this growth has been driven by factors such as the increasing elderly population, a higher incidence of cardiovascular diseases, the development of diagnostic imaging facilities, greater adoption of CT and MRI systems, and improved understanding of the dangers associated with vascular calcification.
The market for cardiovascular calcification is projected to experience robust expansion over the coming years. This market is forecast to reach $2.78 billion by 2030, driven by a compound annual growth rate (CAGR) of 7.9%. Factors contributing to this growth during the forecast period include a heightened demand for accurate cardiovascular diagnostics, a surge in the use of AI-assisted imaging analysis, the widening availability of minimally invasive diagnostic methods, increasing financial commitments to preventive cardiology, and a greater emphasis on early intervention approaches. Key trends anticipated for this period encompass the growing embrace of sophisticated cardiovascular imaging techniques, an increase in the application of calcium scoring and risk assessment tools, the deeper incorporation of artificial intelligence into diagnostic imaging, the spread of catheter-based diagnostic innovations, and an intensified concentration on identifying diseases at earlier stages.
Access Your Free Sample Report For In-Depth Market Analysis:
https://www.thebusinessresearchcompany.com/sample.aspx?id=33053&type=smp
What Primary Drivers Are Shaping The Cardiovascular Calcification Market?
The increasing prevalence of cardiovascular diseases is projected to boost the growth of the cardiovascular calcification market moving forward. These conditions negatively impact the heart and blood vessels, leading to complications such as heart disease, stroke, and high blood pressure. The rise in cardiovascular diseases is primarily fueled by inactive lifestyles and poor dietary choices, which elevate risks like hypertension, obesity, and arterial damage. Cardiovascular calcification is beneficial in the context of cardiovascular diseases as it serves as a marker for atherosclerosis and plaque buildup, enabling early detection of cardiac and vascular damage and guiding preventive or therapeutic interventions. For instance, in August 2025, according to the National Institutes of Health, a US-based government agency, between 2025 and 2050, cardiovascular prevalence is projected to rise by 90%, mortality by 73%, and DALYs by 55%, with deaths increasing from 20.5 million to 35.6 million. Thus, the growing incidence of cardiovascular diseases is propelling the expansion of the cardiovascular calcification market.
How Is The Cardiovascular Calcification Market Organized By Segment Classification?
The cardiovascular calcification market covered in this report is segmented –
1) By Product Type: Imaging Systems; Atherectomy Devices; Stents; Transcatheter Valves
2) By Diagnosis: Computed Tomography (CT) Calcium Scoring; Echocardiography; Intravascular Ultrasound; Biomarkers
3) By Application: Coronary Artery Disease; Aortic Valve Stenosis; Peripheral Artery Disease; Chronic Kidney Disease (CKD) Related Vascular Calcification
4) By End User: Hospitals; Ambulatory Surgical Centers; Cardiac Clinics; Dialysis And Nephrology Centers
Subsegments:
1) By Imaging Systems: Magnetic Resonance Imaging; Computed Tomography Imaging; Ultrasound Imaging; Nuclear Imaging
2) By Atherectomy Devices: Rotational Atherectomy Devices; Directional Atherectomy Devices; Orbital Atherectomy Devices; Laser Atherectomy Devices
3) By Stents: Drug Eluting Stents; Bare Metal Stents; Bioabsorbable Stents; Balloon Expandable Stents
4) By Transcatheter Valves: Transcatheter Aortic Valves; Transcatheter Mitral Valves; Transcatheter Pulmonary Valves; Transcatheter Tricuspid Valves
What Trends Are Affecting The Growth Of The Cardiovascular Calcification Market?
Major companies within the cardiovascular calcification market are focusing on developing innovative solutions, such as targeted intravascular shockwave energy delivery technology, to enhance the treatment of heavily calcified lesions by improving lesion crossing, vessel compliance, and procedural success rates. This targeted intravascular shockwave energy delivery technology is a catheter-based therapy that emits controlled acoustic pressure waves within blood vessels to fracture calcified plaque while preserving surrounding soft tissue and vessel integrity. For instance, in March 2025, Shockwave Medical Inc., a US-based medical device company, launched a novel forward intravascular lithotripsy platform in the US, aimed at transforming the treatment of difficult-to-cross calcified lesions. This technology utilizes forward sonic pressure waves to fracture calcium in challenging calcified peripheral artery lesions without requiring balloon inflation. Its purpose is to enable safe catheter advancement and vessel modification in complex PAD cases such as CLTI, thereby improving outcomes over traditional tools. Key advantages include a 99% technical success rate, minimal complications (1.1% major events), reduced perforation or embolization risks, and enhanced efficiency for below-the-knee treatments, as demonstrated in FORWARD PAD trial data.
Who Are The Industry Participants Involved In The Cardiovascular Calcification Market?
Major companies operating in the cardiovascular calcification market are Abbott Laboratories, Medtronic plc, Siemens Healthineers AG, Fujifilm Holdings Corporation, Royal Philips Healthcare, GE HealthCare Technologies Inc., Boston Scientific Corporation, Shimadzu Corporation, HeartFlow Inc., Aidoc Ltd., Neusoft Medical Systems Co. Ltd., Medis Medical Imaging Systems B.V., Pie Medical Imaging B.V., Canon Medical Systems Corporation, Keya Medical Technology Co. Ltd., Coreline Soft Co. Ltd., FastWave Medical Inc., Cleerly Inc., United Imaging Healthcare Co. Ltd., Zebra Medical Vision Ltd., Circle Cardiovascular Imaging Inc
Get The Full Cardiovascular Calcification Market Report:
https://www.thebusinessresearchcompany.com/report/cardiovascular-calcification-market-report
Which Region Accounts For The Largest Portion Of The Cardiovascular Calcification Market?
North America was the largest region in the cardiovascular calcification market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cardiovascular calcification market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Cardiovascular Calcification Market Report For Competitive Insights:
https://www.thebusinessresearchcompany.com/customise?id=33053&type=smp
Browse Through More Reports Similar to the Global Cardiovascular Calcification Market 2026, By The Business Research Company
Cardiovascular Health Supplements Market Report 2026
Cardiovascular Clinical Trials Market Report 2026
Biopreservation Market Report 2026
https://www.thebusinessresearchcompany.com/report/biopreservation-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model